Dissecting the role of CB1 receptors on chronic liver diseases

Gut

Volumn 62, Issue 7, 2013, Pages 957-958

  Bataller, Ramon ^a   Gao, Bin ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CYTOCHROME P450 2E1;

ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; CHRONIC LIVER DISEASE; DOWN REGULATION; HUMAN; KUPFFER CELL; LIPOGENESIS; MOLECULAR PATHOLOGY; NONHUMAN; NOTE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION;

ALCOHOLIC LIVER DISEASE; OXIDATIVE STRESS;

ANIMALS; CYTOCHROME P-450 CYP2E1; LIVER DISEASES, ALCOHOLIC; MALE; RECEPTOR, CANNABINOID, CB1; RECEPTORS, ESTROGEN;

EID: 84878758083     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2012-303664     Document Type: Note

References (9)

1. Gao B, Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 2011;141:1572-85.
2. Tam J, Liu J, Mukhopadhyay B, et al. Endocannabinoids in liver disease. Hepatology 2011;53:346-55.
3. Louvet A, Teixeira-Clerc F, Chobert MN, et al. Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating Kupffer cell polarization in mice. Hepatology 2011;54:1217-6.
4. Jeong WI, Osei-Hyiaman D, Park O, et al. Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver. Cell Metab 2008; 7:227-35. (Pubitemid 351285525)
5. Kim DK, Jang H, Park J, et al. Estrogen-related receptor gamma controls hepatic CB1 receptor-mediated CYP2E1 expression and oxidative liver injury by alcohol. Gut 2013;62:1044-54.
6. Osei-Hyiaman D, Liu J, Zhou L, et al. Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice. J Clin Invest 2008;118:3160-9.
7. Kunos G, Osei-Hyiaman D, Bátkai S, et al. Should peripheral CB(1) cannabinoid receptors be selectively targeted for therapeutic gain? Trends Pharmacol Sci 2009;30:1-7.
8. Leung TM, Nieto N. CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease. J Hepatol Published Online First: 28 Aug 2012. doi: 10.1016/j.jhep.2012.08.018
9. Vluggens A, Reddy JK. Nuclear receptors and transcription factors in the development of fatty liver disease. Curr Drug Metab 2012 (in press).